Thromboxane/prostaglandin endoperoxide-induced hypertrophy of rat vascular smooth muscle cells is signaled by protein kinase C-dependent increases in transforming growth factor-β

Hypertension

Volumn 28, Issue 2, 1996, Pages 169-176

  Craven, Patricia A ^a,b   Studer, Rebecca K ^a   DeRubertis, Frederick R ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

fibroblast growth factor, basic; hypertrophy; muscle, smooth, vascular; protein kinase C; transforming growth factor beta

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; BASIC FIBROBLAST GROWTH FACTOR; PROSTAGLANDIN ENDOPEROXIDE; PROTEIN KINASE C; THROMBOXANE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

EID: 0029780772     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.2.169     Document Type: Article

References (30)

1. Dorn GW, Becker MW, Davis MG. Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle. J Biol Chem. 1992;267:24897-24905.
2. 2 stimulates vascular smooth muscle hypertrophy by up-regulating the synthesis and release of endogenous basic fibroblast growth factor. J Biol Chem. 1993;286:17397-17403.
3. Itoh H, Mukoyama M, Pratt RE, Gibbons GH, Dzau VJ. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest. 1993;91:2268-2274.
4. Gibbons GH, Pratt RE, Dzau VJ. Vascular smooth muscle cell hypertrophy vs hyperplasia: autocrine transforming growth factor β expression determines growth response to angiotensin II. J Clin Invest. 1992;90:456-461.
5. Ishimitsu T, Uehara Y, Ishii M, Ikeda T, Matsuoka H, Sugimoto T. Thromboxane and vascular smooth muscle cell growth in genetically hypertensive rats. Hypertension. 1988;12:46-51.
6. 2 in vascular smooth muscle cells. Biochem Pharmacol. 1990;40:2535-2542.
7. 2 on proliferation of vascular smooth muscle cells from rats. Am J Physiol. 1992; 263:H1331-H1338.
8. 2-stimulated mitogenesis of coronary artery smooth muscle cells involves activation of mitogen-activated protein kinase and S6 kinase. J Biol Chem. 1994;269:5693-5698.
9. 2 stimulated signal transduction in vascular smooth muscle. J Pharmacol Exp Ther. 1993;265:447-456.
10. Ali S, Becker MW, Davis MG, Dorn GW. Dissociation of vasoconstrictor stimulated basic fibroblast growth factor expression from hypertrophic growth in cultured vascular smooth muscle cells: relevant roles of protein kinase C. Circ Res. 1994;75:836-843.
11. Studer RK, Negrete H, Craven PA, DeRubertis FR. Protein kinase C signals thromboxane induced increases and TGF-beta bioactivity in mesangial cells. Kidney Int. 1995;48:422-430.
12. Ross R. The smooth muscle cell, II: growth of smooth muscle in culture. J Cell Biol. 1971;50:172-186.
13. Libby P, O'Brien KY. Culture of quiescent arterial smooth muscle cells in a defined serum-free medium. J Cell Physiol. 1983;115: 217-223.
14. Lawrence DA, Pircher R, Jullien P. Conversion of a high molecular weight latent β-TGF from chicken embryo fibroblasts into a low molecular weight active β-TGF under acidic conditions. Biochem Biophys Res Commun. 1985;133:1026-1034.
15. Danielpour D, Dart LL, Flanders KC, Roberts AB, Sporn MB. Immuno-detection and quantitation of the two forms of transforming growth factor-beta (TGFβ1 and TGFβ2) secreted by cells in culture. J Cell Physiol. 1989;138:79-86.
16. Studer RK, Craven PA, DeRubertis FR. Low density lipoprotein stimulation of mesangial cell fibronectin synthesis: role of protein kinase C and transforming growth factor β. J Lab Clin Med. 1995; 125:86-95.
17. Chakravarthy BR, Bussey A, Whitfield JF, Sikorska M, Williams RE, Durkin JP. The direct measurement of protein kinase C (PKC) activity in isolated membranes using a selective peptide substrate. Anal Biochem. 1991;196:144-150.
18. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Bandet V, Boissin P, Boursier E, Loriolle F, Duhame L, Charon D, Kirilovsky J. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem. 1991;266:15771-15781.
19. Tamaoki T. Use and specificity of staurosporine, UCN-01 and calphostin C as protein kinase inhibitors. Methods Enzymol. 1991; 201:340-347.
20. Owens GK, Geisterfer AAT, Yang YW-H, Komoriya A. Transforming growth factor β induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells. J Cell Biol. 1988; 107:771-780.
21. Battegay EJ, Raines EW, Seifert RA, Bowen-Pope DF, Ross R. TGFβ induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell. 1990;63:515-524.
22. Maiack RA. Beta type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures. J Cell Biol. 1987;105:465-471.
23. Agrotis A, Saltis J, Bobik A. Transforming growth factor-β1 gene activation and growth of smooth muscle from hypertensive rats. Hypertension. 1994;23:593-599.
24. Kim SJ, Denhez F, Kim KY, Holt JT, Sporn MB, Roberts AB. Activation of the second promoter of the transforming growth factor beta-1 gene by transforming growth factor beta-1 and phorbol ester occurs through the same target sequences. J Biol Chem. 1989; 264:19373-19378.
25. Akhurst RJ, Fee R, Balmain A. Localized production of TGFβ mRNA in tumor promoter stimulated mouse epidermis. Nature. 1988;331:363-365.
26. Kaname S, Uchida S, Ogata E, Kurokawa K. Autocrine secretion of transforming growth factor-β in cultured rat mesangial cells. Kidney Int. 1992;42:1319-1327.
27. Au YPT, Kenagy RD, Clowes AW. Heparin selectivity inhibits the transcription of tissue type plasminogen activator in primate arterial smooth muscle cells during mitogenesis. J Biol Chem. 1992;267: 3438-3444.
28. Flaumenhaft R, Abe M, Mugnatti P, Rifkin DB. Basic FGF-induced activation of latent TGFβ1 in endothelial cells: regulation of plasminogen activator activity. J Cell Biol. 1992;118:901-909.
29. Antonelli-Orlidge A, Sauders KB, Smith SR, D'Amore PA An activated form of TGFβ is produced by co-culture of endothelial cells and pericytes. Proc Natl Acad Sci U S A. 1989;86:4544-4548.
30. Sato Y, Rifkin DB. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-β1 like molecule by plasmin during co-culture. J Cell Biol. 1989;109:309-315.